Gilad Peleg (Lorberbaum) has 25 years of experience in life sciences management, including blue chip corporate pharma business development, the launching of innovative start-ups, and venture capital / private equity portfolio management.
From 2008 (foundation), up to late 2015, Gilad was C.O.O at Rainbow Medical Ltd., an operational investment company, with over a dozen fully owned subsidiaries, tens of pipeline projects, and over $200M in investments. Earlier on in 2006, Gilad was CEO in residence at Glenrock Israel private equity family office, and from 2002, CEO at NanoCyte Inc., leading the company from idea to clinical proof of concept. In year 1999, Gilad was VP at Reico Venture Capital managing the med tech portfolio, and thereafter was Co-Founder of Oncosurge technology. Between 1993 and 1999, Gilad was with Teva Pharmaceutical Industries (TEVA, NYSE), initially as Finance Manager at Teva R&D division, and thereafter Business Development Director at Teva headquarters.
Gilad holds a Bachelor’s degree in Economics and Political Science from the Hebrew University of Jerusalem, Israel, and an MBA from the University of Hartford, Connecticut, USA.
- On 2017年9月19日